INTEGRATED BIOPHARMA INC Interest Expense, Lessee, Assets under Capital Lease
INTEGRATED BIOPHARMA INC (INBP) reported Interest Expense, Lessee, Assets under Capital Lease of $2.00 thousand for the 12-month period ending 2021-06-30, per its 10-K filed 2021-09-02.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseLesseeAssetsUnderCapitalLease · last filed 2021-09-02
- INTEGRATED BIOPHARMA INC interest expense, lessee, assets under capital lease for fiscal 2021 was $2.00K, a 84.62% decline from fiscal 2020.
- INTEGRATED BIOPHARMA INC interest expense, lessee, assets under capital lease for fiscal 2020 was $13.00K, a 31.58% decline from fiscal 2019.
- INTEGRATED BIOPHARMA INC interest expense, lessee, assets under capital lease for fiscal 2019 was $19.00K, a 24.00% decline from fiscal 2018.
- INTEGRATED BIOPHARMA INC interest expense, lessee, assets under capital lease for fiscal 2018 was $25.00K, a 0.00% change from fiscal 2017.
| Period end | Interest Expense, Lessee, Assets under Capital Lease 12 month |
|---|---|
| 2021-06-30 | $2.00K 10-K · filed 2021-09-02 |
| 2020-06-30 | $13.00K 10-K · filed 2021-09-02 |
| 2019-06-30 | $19.00K 10-K · filed 2020-09-23 |
| 2018-06-30 | $25.00K 10-K · filed 2019-08-29 |
| 2017-06-30 | $25.00K 10-K · filed 2018-09-12 |
| 2016-06-30 | $13.00K 10-K · filed 2017-09-01 |
| 2015-06-30 | $5.00K 10-K · filed 2016-09-02 |
| 2014-06-30 | $5.00K 10-K · filed 2015-09-04 |
| 2013-06-30 | $2.00K 10-K · filed 2014-09-08 |
| 2012-06-30 | $1.00K 10-K · filed 2013-09-30 |
| 2011-06-30 | $4.00K 10-K · filed 2012-10-15 |